Questions about Alice Mushrooms, answered in the words of the people who did the work. The engagement itself is on its own page.
How was a category with no national leader taken to grocery buyers?
We were an advisor on go-to-market, not the lead on the round, and every product and retail decision stayed with the two founders. The category had never had a national leader on a grocery shelf, so a buyer had no sales history to underwrite. We walked in having already cut that chain's own scan data for the adjacent functional shelf, so the buyer had a number to defend at their own review. Then we weighted the effort toward the national chains first, so their sell-through became the proof for the next tier.
What did the adjacent-shelf scan analysis show the buyer?
Growth in the adjacent category, adaptogenic beverages and the functional wellness shelf, already happening in that buyer's own stores, cut to their own chain and their own category hierarchy. The point was the source: syndicated scan data the buyer already subscribed to and trusted, so the category-creation pitch read as an extension of a trend their own numbers supported rather than an isolated bet. It made the bet arguable. It did not make it safe, and we never said it did, because a new format failing at a national chain with nothing comparable behind it is a real delisting risk.
Once national placements went live, how did early sell-through affect the next retail conversations?
The sell-through numbers are the company's, so we will leave them with the founders. What changed was what the next buyer was looking at: the brand's own sell-through at a national chain instead of a proxy, which is what every later buyer asks for. Syndicated data reports on a delay, so the risk was a win sitting unused until somebody remembered it. That is why the standing advisor update carried a pipeline line beside the door count, so each new win was repackaged for the next buyer as soon as the data existed. Even with every Target and every Sprouts counted, a real share of the doors sits with regional chains and independents.
What was sharpened for the fundraising story?
There was not much to sharpen. Institutional money was not the plan, and the proof was in the sales. We focused on what the founders were really good at: branding, marketing, and their Hollywood and LA connections. We also worked new angles for pitching the benefits of mushrooms, their sleep, mood and sex versions. When you work with good people and a great brand, options show up that nobody planned for.
How did reframing the brand around the founders' relationships change what the team could credibly pitch?
A lot of it had to do with getting their Hollywood connections on board. They are really great marketers and branders, and they had ideas about how to make mushrooms sexy, so it was easy. Their celebrity endorsers, who were also investors, got behind those stories and wanted to attach themselves to them, and the list of people involved goes on and on.